Abstract
Existing diagnostic and therapeutic strategies for central nervous system (CNS) disorders are restricted to access the CNS. Meanwhile, the blood–brain barrier (BBB) hinders the delivery of many potentially important diagnostic and therapeutic agents to the brain. To resolve these problems, various nanoformulation technologies were developed to improve the delivery of diagnostic and therapeutic agents into CNS. In this chapter, we discussed the manufacture, characteristics, and potential problems of widely used nanoformulations including liposomes, polymeric micelles, and nanosuspensions. We expect that this chapter would provide novel nanoformulation tools for the basic and clinical research of neuroscientists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB (2005) The liposomal formulation of doxorubicin. Methods Enzymol 391:71–97
Balkundi S, Nowacek AS, Roy U, Martinez-Skinner A, McMillan J, Gendelman HE (2010) Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs. J Vis Exp (46): 2460
Batrakova EV, Kabanov AV (2008) Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98–106
Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183:661–669
Fan J, Zhang Y, Chuang-Smith ON, Frank KL, Guenther BD, Kern M, Schlievert PM, Herzberg MC (2012) Ecto-5′-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. PLoS One 7(6):e38059
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171
Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S (2003) In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res 9:6551–6559
Gaitanis A, Staal S (2010) Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. Methods Mol Biol 624:385–392
Gast K, Zirwer D, Ladhoff AM, Schreiber J, Koelsch R, Kretschmer K, Lasch J (1982) Auto-oxidation-induced fusion of lipid vesicles. Biochim Biophys Acta 686:99–109
Gilmore JL, Yi X, Quan L, Kabanov AV (2008) Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 3:83–94
Groothuis DR (2000) The blood–brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2:45–59
Haney MJ, Zhao Y, Li S, Higginbotham SM, Booth SL, Han HY, Vetro JA, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV (2011) Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. Nanomedicine (Lond) 6:1215–1230
Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1:297–315
Junghanns JU, Muller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 3:295–309
Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 54:759–779
Kadiu I, Nowacek A, McMillan J, Gendelman HE (2011) Macrophage endocytic trafficking of antiretroviral nanoparticles. Nanomedicine (Lond) 6:975–994
Kanmogne GD, Singh S, Roy U, Liu XM, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautum N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE (2012) Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell targeted nanoformulated antiretroviral drugs to human brain endothelial cells. Int J Nanomedicine 7:2373–2388
Kohori F, Yokoyama M, Sakai K, Okano T (2002) Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J Control Release 78:155–163
Krauze MT, Noble CO, Kawaguchi T, Drummond D, Kirpotin DB, Yamashita Y, Kullberg E, Forsayeth J, Park JW, Bankiewicz KS (2007) Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro Oncol 9:393–403
Loch-Neckel G, Koepp J (2010) The blood–brain barrier and drug delivery in the central nervous system. Rev Neurol 51:165–174
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284
Maruyama K (2011) Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63:161–169
Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81–104
Modi G, Pillay V, Choonara YE (2010) Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci 1184:154–172
Nowacek AS, McMillan J, Miller R, Anderson A, Rabinow B, Gendelman HE (2010) Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics. J Neuroimmune Pharmacol 5:592–601
Nowacek AS, Balkundi S, McMillan J, Roy U, Martinez-Skinner A, Mosley RL, Kanmogne G, Kabanov AV, Bronich T, Gendelman HE (2011) Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J Control Release 150:204–211
Oh KT, Bronich TK, Kabanov AV (2004) Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release 94:411–422
Orlacchio A, Bernardi G, Orlacchio A, Martino S (2010) Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr Med Chem 17:595–608
Patravale VB, Date AA, Kulkarni RM (2004) Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827–840
Shao K, Huang R, Li J, Han L, Ye L, Lou J, Jiang C (2010) Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. J Control Release 147:118–126
Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160
Van Eerdenbrugh B, Van den Mooter G, Augustijns P (2008) Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64–75
Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, Cruz I, Xiang LM, Pirollo KF, Chang EH (2002) Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 1:337–346
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Liu, XM., Bronich, T.K. (2014). Nanoformulations. In: Xiong, H., Gendelman, H.E. (eds) Current Laboratory Methods in Neuroscience Research. Springer Protocols Handbooks. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8794-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8794-4_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8793-7
Online ISBN: 978-1-4614-8794-4
eBook Packages: Springer Protocols